Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
DOI
PMC
 |
|
Open Access Green as soon as Postprint is submitted to ZB.
Clinical use of adjuvants in allergen-immunotherapy.
Expert Rev. Clin. Immunol. 13, 599-610 (2017)
Introduction Allergen-specific Immunotherapy (AIT) is the only available treatment aimed to tackle the underlying causes of allergy. The active components of subcutaneous vaccines traditionally consist of natural or modified allergen extracts which can be combined with adjuvant platforms. In recent years new targets have been further developed in an attempt to raise the safety and efficacy profile of AIT. Areas Covered In this review, we discuss the desirable attributes of adjuvants and delivery systems from empiricism to rational design, for current and future clinical applications in AIT. Expert Summary The introduction of novel adjuvants, in combination with active targets, has been demonstrated to reduce side-effects of AIT, increase clinical efficacy of allergy treatment and reduce the number of doses. The evolution of vaccine development for AIT is entering a phase of scientific progress that challenges dogmas. Over the past century the traditional concept of immunotherapy, entailing long-course administration of native extract preparations and first generation adjuvants has seen evolution in the past decade from proof-of-concept to clinical development pipelines encompassing the advent of second generation adjuvants and delivery systems that form essential components of modern AIT development.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
Allergic Rhinitis ; Cpg-motifs ; Monophosphoryl Lipid A ; Adjuvant ; Microcrystalline Tyrosine ; Nanoparticles ; Subcutaneous ; Vaccine; Monophosphoryl-lipid-a; Virus-like Particles; Peanut Oral Immunotherapy; Aluminum Adjuvants; Immune-responses; Apoptotic Cells; Dendritic Cells; Vaccine Development; Nalp3 Inflammasome; Structural Basis
ISSN (print) / ISBN
1744-666X
Quellenangaben
Volume: 13,
Issue: 6,
Pages: 599-610
Publisher
Expert Reviews
Publishing Place
London
Non-patent literature
Publications
Reviewing status
Peer reviewed
Institute(s)
Institute for Allergy Research (IAF)